glp 1 canada CPHA: Now Second-Largest GLP-1 User Market Globally GLP-1 Supplements Guide for Canadians
Description
Your guide to understanding long-term GLP-1 use, weight maintenance, and what your body needs for sustainable results.
Bariatric Fusion GLP-ONE + Receptor Activator features two clinically validated botanical ingredients: hops extract (20% xanthohumulone) and copaiba extract (10% beta-caryophyllene)
Understanding the distinction between natural stimulants and prescription GLP-1 medications helps patients make informed choices about weight management
The global incretin-based drugs market was valued at USD 39.4 billion in 2025 and is projected to grow from USD 41.6 billion in 2026 to USD 72.6 billion by 2035, expanding at a CAGR of 6.4% between 2026 and 2035, driven by the rising prevalence of type 2 diabetes mellitus.
From skin and hair concerns to shifts in spend and routines, this is a structural change, not a passing trend!!
